Detalhe da pesquisa
1.
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I.
Invest New Drugs
; 42(1): 44-52, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38055127
2.
Impact of telephone follow-up on hepatocellular carcinoma patients receiving oral chemotherapy from an ambulatory-care setting.
J Oncol Pharm Pract
; : 10781552231215427, 2023 Dec 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38043932
3.
[Multi-Center Joint Study on the Survey of Antiemetic Therapy for the Prevention of Nausea and Vomiting in Combination Therapy with a Mild Emetic Antineoplastic Drug].
Gan To Kagaku Ryoho
; 46(10): 1553-1559, 2019 Oct.
Artigo
Japonês
| MEDLINE | ID: mdl-31631138
4.
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.
JAMA Netw Open
; 6(5): e2310894, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37129897